Larvol Delta - Dosing-of-first-patient-with-ARR002-in-a-Phase-1-trial-expected-in-the-second-half-of-2026

ARR-002 - ArriVent

https://www.manilatimes.net/2026/05/12/tmt-newswire/globenewswire/arrivent-biopharma-reports-first-quarter-2026-financial-results/2341089/amp

May 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next